Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B85

Crystal Structure of EGFR-WT in Complex with TAK-788

7B85 の概要
エントリーDOI10.2210/pdb7b85/pdb
分子名称Epidermal growth factor receptor, propan-2-yl 2-[[4-[2-(dimethylamino)ethyl-methyl-amino]-2-methoxy-5-(propanoylamino)phenyl]amino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, ... (4 entities in total)
機能のキーワードegfr, wt, exon20, covalent, transferase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計38658.70
構造登録者
Niggenaber, J.,Mueller, M.P.,Rauh, D. (登録日: 2020-12-12, 公開日: 2022-02-23, 最終更新日: 2024-11-20)
主引用文献Lategahn, J.,Tumbrink, H.L.,Schultz-Fademrecht, C.,Heimsoeth, A.,Werr, L.,Niggenaber, J.,Keul, M.,Parmaksiz, F.,Baumann, M.,Menninger, S.,Zent, E.,Landel, I.,Weisner, J.,Jeyakumar, K.,Heyden, L.,Russ, N.,Muller, F.,Lorenz, C.,Bragelmann, J.,Spille, I.,Grabe, T.,Muller, M.P.,Heuckmann, J.M.,Klebl, B.M.,Nussbaumer, P.,Sos, M.L.,Rauh, D.
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.
J.Med.Chem., 65:6643-6655, 2022
Cited by
PubMed Abstract: Despite the clinical efficacy of epidermal growth factor receptor (EGFR) inhibitors, a subset of patients with non-small cell lung cancer displays insertion mutations in exon20 in EGFR and Her2 with limited treatment options. Here, we present the development and characterization of the novel covalent inhibitors LDC8201 and LDC0496 based on a 1-pyrrolo[2,3-]pyridine scaffold. They exhibited intense inhibitory potency toward EGFR and Her2 exon20 insertion mutations as well as selectivity over wild type EGFR and within the kinome. Complex crystal structures with the inhibitors and biochemical and cellular on-target activity document their favorable binding characteristics. Ultimately, we observed tumor shrinkage in mice engrafted with patient-derived EGFR-H773_V774insNPH mutant cells during treatment with LDC8201. Together, these results highlight the potential of covalent pyrrolopyridines as inhibitors to target exon20 insertion mutations.
PubMed: 35486541
DOI: 10.1021/acs.jmedchem.1c02080
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.5 Å)
構造検証レポート
Validation report summary of 7b85
検証レポート(詳細版)ダウンロードをダウンロード

229380

件を2024-12-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon